TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Chilean health regulator approves Sinovac use among children over age 6
The South American country has already approved the use of the Pfizer Inc/BioNTech vaccine for children over 12, with 654,053 receiving at least one dose since May.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A nurse administers CoronaVac, a Sinovac's potential vaccine against the coronavirus disease (COVID-19), to a volunteer and nurse Sarah Rangon at Emilio Ribas Institute in Sao Paulo, Brazil July 30, 2020. Picture taken July 30, 2020. (REUTERS/Amanda Perobelli)
T
he Chilean health regulator on Monday approved the COVID-19 vaccine produced by China's Sinovac Biotech for use in children over 6 years of age, allowing more people to be included in the country's rapid inoculation campaign.
The South American country has already approved the use of the Pfizer Inc/BioNTech vaccine for children over 12, with 654,053 receiving at least one dose since May.
Sinovac's CoronaVac has formed the backbone, however, of Chile's vaccination campaign, which has seen more than 13 million of the country's 19 million inhabitants fully inoculated so far and 19.49 million CoronaVac doses issued in total.
"This is great news for school-age children and those that were not included in previous vaccination plans," said Health Minister Enrique Paris.
Five of the experts on the evaluation panel convened by the Institute of Public Health (ISP) voted in favor of applying the shot to children over 6, while two voted in favor of issuing it only to those over 12, and one voted against issuing it to children.
Read also: Vaccination in Indonesia: Greed amid the pandemic?
CoronaVac also has emergency approval for use in children in Indonesia and China.
Chile has seen in recent weeks a noticeable drop in infections, recording just 435 new cases on Monday. It has had a total of 1.6 million confirmed COVID-19 cases and 37,108 deaths.
